New strategies in motor parkinsonism

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Antonini, Angelo ^a  

^a PARKINSON INSTITUTE   (Italy)

Author keywords

Apomorphine; Continuous duodenal levodopa delivery; Deep brain stimulation; Dyskinesias; Motor fluctuations; Parkinson's disease

Indexed keywords

APOMORPHINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; RASAGILINE; SELEGILINE; TOLCAPONE;

ARTICLE; BRAIN DEPTH STIMULATION; CONTINUOUS INFUSION; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG MEGADOSE; DYSKINESIA; HUMAN; MOTOR CONTROL; MOTOR DYSFUNCTION; NEUROMODULATION; PARKINSON DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN MANIFESTATION; SUBTHALAMIC NUCLEUS;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; HUMANS; MOTOR SKILLS; PARKINSONIAN DISORDERS;

EID: 38949114576     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70047-6     Document Type: Article

References (15)

1. Nutt J., and Holford N. The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 39 (1996) 561-573
2. Masden C., and Parkers J. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1 (1977) 345-349
3. Lang A., and Lozano A. Parkinson's disease. Part 2. N England J Med 339 (1998) 1130-1143 Review.
4. Hauser R., McDermott M., and Messing S. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson Disease. Arch Neurol 63 (2006) 1756-1760
5. Schrag A., and Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 123 (2000) 2297-2305
6. Widnell K., and Comella C. Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations. Mov Disord 20 Suppl 11 (2005) 30-37
7. Deane K., Spieker S., and Clarke C. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev 4 (2004 Oct 18) 2005.
8. De Gaspari D., Siri C., Landi A., Cilia R., Bonetti A., Natuzzi F., et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 77 (2006) 450-453
9. Derost P., Ouchchane L., Morand D., Ulla M., Llorca P., Barget M., et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population. Neurology 68 17 (2007) 1345-1355
10. Kurth M., Tetrud J., Tanner C., Irwin I., Stebbins G., Goetz C., et al. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations. Neurology 43 (1993) 1698-1703
11. Nyholm D., Nilsson Remahl A., Dizdar N., Constantinescu R., Holmberg B., Jansson R., et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64 2 (2005) 216-223
12. Antonini A., Isaias I., Canesi M., Zibetti M., Mancini F., Manfredi L., et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 22 (2007) 1145-1149
13. Rodriguez-Oroz M., Obeso J., Lang A., Houeto J., Pollak P., Rehncrona S., et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128 (2005) 2240-2249
14. Morgante L, Morgante F, Moro E, Epifanio A, Girlanda P, Ragonese P, et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 2007 Oct 30 [Epub ahead of print].
15. Antonini A. Continuous dopaminergic stimulation - From theory to clinical practice. Parkinsonism Relat Disord (2007 Aug 14)